Tender detail
Open-house discount agreements for medicines containing apixaban
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient apixaban (ATC B01AF02), covering the period from 1 December 2026 to 30 November 2028. Agreements may be concluded at any time during this period under an open-house model. Medicines listed as paediatric medicines by the German Federal Institute for Drugs and Medical Devices are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.